Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Sequential Therapy and Autologous Transplant for Multiple Myeloma
NCT00349778Phase 2Completed
- Sponsor
- Stanford University
- Start
- Aug 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine in multiple myeloma (MM), sponsored by Stanford University. Started Aug 2006; status: completed.
02
Drugs
carmustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00349778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349778.